Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer ; volume:8 ; number:1 ; day:8 ; month:5 ; year:2018 ; pages:1-13 ; date:12.2018
Scientific reports ; 8, Heft 1 (8.5.2018), 1-13, 12.2018
- Creator
-
Kumar, Binod
- Contributor
-
Rosenberg, Avi Z.
Choi, Su Mi
Fox-Talbot, Karen
Marzo, Angelo M. De
Nonn, Larisa
Brennen, W. Nathaniel
Marchionni, Luigi
Halushka, Marc K.
Lupold, Shawn E.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-25320-z
- URN
-
urn:nbn:de:101:1-2018080710103190267902
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kumar, Binod
- Rosenberg, Avi Z.
- Choi, Su Mi
- Fox-Talbot, Karen
- Marzo, Angelo M. De
- Nonn, Larisa
- Brennen, W. Nathaniel
- Marchionni, Luigi
- Halushka, Marc K.
- Lupold, Shawn E.
- SpringerLink (Online service)
Other Objects (12)
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer
Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel
Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate
Microfluidic-based prostate cancer model for investigating the secretion of prostate-specific antigen and microRNAs in vitro
CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Recent updates on the role of microRNAs in prostate cancer
Molecular assays for the detection of microRNAs in prostate cancer
Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
Circulating microRNAs (miRNA) in serum of patients with prostate cancer
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer
Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel
Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate
Microfluidic-based prostate cancer model for investigating the secretion of prostate-specific antigen and microRNAs in vitro
CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Recent updates on the role of microRNAs in prostate cancer
Molecular assays for the detection of microRNAs in prostate cancer
Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
Circulating microRNAs (miRNA) in serum of patients with prostate cancer
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer
Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel
Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate
Microfluidic-based prostate cancer model for investigating the secretion of prostate-specific antigen and microRNAs in vitro
CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Recent updates on the role of microRNAs in prostate cancer
Molecular assays for the detection of microRNAs in prostate cancer
Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
Circulating microRNAs (miRNA) in serum of patients with prostate cancer